Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.?W
Share ThisFacebookTwitterWhatsAppPinterestShare This
Description
Reviews
There are no reviews yet.